Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jean-jaques Grob"'
Autor:
Celeste Lebbe, Shailender Bhatia, Melissa Burgess, Jean-Jaques Grob, Sadhna Shankar, Giovanni Grignani, Piotr Rutkowski, Michele Guida, Chuan Tian, Natalie Prinzi, Enrica Teresa Tanda, Jennifer Pulini
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/db63b1bf4b0b42ea978e3082b7d0ba5f
Autor:
Andrew Haydon, Celeste Lebbe, Jose Lutzky, Gregory Daniels, Ragini Kudchadkar, Ann Silk, Nikhil Khushalani, Frances Collichio, Jean-Jaques Grob, Samantha Bowyer, Praveen Bommareddy, Andrew Hill, Danny Rischin, Daniel Brungs, Michael Migden, Matthew Fury, Jenny Lee, Muhammad Alamgeer, Dimitrios Colevas, Wanxing Chai-Ho, Piyush Sheladia, Shui He, Claudia Andreu-Vieyra
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/167192fa3f6d4054be25ce205537925e
Autor:
Sandra D'Angelo, Celeste Lebbé, Laurent Mortier, Andrew Brohl, Nicola Fazio, Jean-jaques Grob, Natalie Prinzi, Glenn Hanna, Jessica Hassel, Felix Kiecker, Anja von Heydebreck, Gülseren Güzel, Paul Nghiem
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Wanxing Chai-Ho, Jenny H. Lee, Ignacio Melero, Andrew Haydon, Nikhil I. Khushalani, Jose Lutzky, Andrew F. Hill, Gregory A. Daniels, Muhammad Alamgeer, Ragini R. Kudchadkar, Dimitrios Colevas, Ann Silk, Piyush Sheladia, Daniel Brungs, Shui He, Praveen K. Bommareddy, Frances A. Collichio, Samantha Bowyer, Céleste Lebbé, Michael R. Migden, Danny Rischin, Jean-jaques Grob, Matthew G. Fury, Claudia Andreu-Vieyra
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundThe prognosis for advanced and metastatic cutaneous squamous cell carcinoma (CSCC) remains poor for many patients with the disease despite approval of the anti-PD1 antibodies cemiplimab and pembrolizumab.1 2 RP1 is an oncolytic virus (HSV-1
Autor:
Piotr Rutkowski, Giovanni Grignani, Enrica Teresa Tanda, Melissa Amber Burgess, Sadhna Shankar, Natalie Prinzi, Jean-jaques Grob, Michele Guida, Shailender Bhatia, Jennifer Pulini, Chuan Tian, Céleste Lebbé
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundRetifanlimab (INCMGA00012) is a humanized, hinge-stabilized immunoglobulin G4 kappa (IgG4κ), anti-programmed cell death protein (PD)-1 monoclonal antibody with safety and clinical pharmacology that are characteristic for the class. Evaluat
Autor:
Luigi Naldi, Jean-Jaques Grob
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 11:S19